Eton Pharmaceuticals, Inc.
ETON
$16.90
-$2.24-11.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.45% | -64.44% | -162.88% | -195.37% | 120.62% |
| Total Depreciation and Amortization | 0.40% | -0.79% | 185.35% | 27.70% | -0.36% |
| Total Amortization of Deferred Charges | 91.03% | -73.47% | -70.18% | 7,142.86% | -123.73% |
| Total Other Non-Cash Items | -25.41% | 39.30% | 176.88% | 9.94% | -5.72% |
| Change in Net Operating Assets | 67.51% | 154,475.00% | 99.83% | -283.51% | -58.99% |
| Cash from Operations | 51.10% | 280.81% | 373.20% | -125.91% | 135.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -95.23% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -98.83% | 8,820.00% | -78.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.53% | 220.41% | 146.65% | -307.44% | 147.06% |